Banque Pictet & Cie Sa Trimmed Honeywell Intl (HON) Position By $4.02 Million; KISSEI PHARMACEUTICALS COMPANY LTD OR (KSPHF) Shorts Down By 0.56%

February 17, 2018 - By Matt Maslow

KISSEI PHARMACEUTICALS COMPANY LTD OR (OTCMKTS:KSPHF) had a decrease of 0.56% in short interest. KSPHF’s SI was 53,400 shares in February as released by FINRA. Its down 0.56% from 53,700 shares previously. With 100 avg volume, 534 days are for KISSEI PHARMACEUTICALS COMPANY LTD OR (OTCMKTS:KSPHF)’s short sellers to cover KSPHF’s short positions. It closed at $26.3 lastly. It is up 0.00% since February 17, 2017 and is . It has underperformed by 16.70% the S&P500.

Banque Pictet & Cie Sa decreased Honeywell Intl Inc (HON) stake by 7.58% reported in 2017Q3 SEC filing. Banque Pictet & Cie Sa sold 28,520 shares as Honeywell Intl Inc (HON)’s stock rose 5.49%. The Banque Pictet & Cie Sa holds 347,645 shares with $49.28 million value, down from 376,165 last quarter. Honeywell Intl Inc now has $115.83 billion valuation. The stock increased 0.40% or $0.61 during the last trading session, reaching $154.03. About 2.80M shares traded. Honeywell International Inc. (NYSE:HON) has risen 17.66% since February 17, 2017 and is uptrending. It has outperformed by 0.96% the S&P500.




Kissei Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in Japan. The company has market cap of $1.22 billion. The firm offers Urief tablets for the treatment of dysuria; and Glufast and Glubes tablets for diabetes; Epoetin Alfa BS injection for the treatment of renal anemia; and P-TOL chewable tablets for treating hyperphosphatemia in patients on dialysis, as well as Silodosin, a drug for the treatment of dysuria. It has a 15.83 P/E ratio. The Company’s products under pipeline includes Rovatirelin/KPS-0373 for treating Spinocerebellar ataxia; Carotegrast Methyl/AJM300 and Budesonide/AJG511 for treating Ulcerative colitis; Ozagrel/KCT-0809 for treating dry-eye with sjögrenÂ’s syndrome; and Vibegron/KRP-114V for overactive bladder that are in Phase III clinical trials.

Banque Pictet & Cie Sa increased Nike Inc (NYSE:NKE) stake by 209,880 shares to 2.70 million valued at $140.23M in 2017Q3. It also upped Baidu Inc (NASDAQ:BIDU) stake by 67,394 shares and now owns 99,327 shares. Accenture Plc Ireland (NYSE:ACN) was raised too.

Investors sentiment increased to 1.14 in Q3 2017. Its up 0.18, from 0.96 in 2017Q2. It increased, as 42 investors sold HON shares while 453 reduced holdings. 99 funds opened positions while 465 raised stakes. 562.75 million shares or 0.04% less from 562.97 million shares in 2017Q2 were reported. Montag & Caldwell Limited Liability Company holds 3.31% or 758,769 shares. Picton Mahoney Asset Mngmt owns 73,175 shares. Davidson & Garrard Inc holds 0.12% of its portfolio in Honeywell International Inc. (NYSE:HON) for 3,717 shares. Montgomery Inv Management accumulated 0.27% or 4,300 shares. The Wisconsin-based Legacy Prns has invested 0.47% in Honeywell International Inc. (NYSE:HON). Oakbrook Invs Ltd Liability Com, a Illinois-based fund reported 32,285 shares. First Wilshire Secs Mngmt Incorporated accumulated 0.08% or 2,100 shares. Cypress Cap, Florida-based fund reported 9,812 shares. Carroll Associate Incorporated reported 0.07% stake. Shelton Capital reported 25,513 shares. Dearborn Prtnrs Ltd Limited Liability Company reported 2,552 shares stake. Parkside Finance Commercial Bank And Tru has 0.08% invested in Honeywell International Inc. (NYSE:HON) for 1,391 shares. Arvest Bancshares Division accumulated 1.29% or 127,759 shares. Moon Cap Management holds 2,559 shares. Oppenheimer Asset Mgmt Incorporated invested in 0.28% or 77,102 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts